Piramal Pharma to host analyst and investor meeting in September

Piramal Pharma Limited will host an analyst and institutional investor meeting with DAM Capital Pharmaceutical Conference on September 23, 2025. This interaction, categorized as a group/one-on-one meeting, will take place in Mumbai. The company informed both BSE Limited and the National Stock Exchange of India Limited about the scheduled event.

The meeting is being conducted in compliance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Piramal Pharma emphasizes that the dates are subject to change, with potential alterations due to exigencies on the part of the investors or the company. Tanya Sanish, company secretary, signed the intimation on September 2, 2025.